SCHEMBL4902877

SCHEMBL4902877

c1cc(-c2nccs2)nc(-c2nccs2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.61
HSP90AA1 P07900 2/20 0.60
PDPK1 O15530 1/20 0.54
SYK P43405 7/20 0.49
SRC P12931 2/20 0.49
ZAP70 P43403 2/20 0.49
CDK2 P24941 1/20 0.49
LOXL2 Q9Y4K0 1/20 0.47
CYP2A6 P11509 1/20 0.47
CYP1A1 P04798 5/20 0.45
CYP1A2 P05177 5/20 0.45
CYP1B1 Q16678 5/20 0.45
KDM4E B2RXH2 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2730329 0.90 RAB9A (0.53) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL16159711 0.87 RAB9A (0.54) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL16159636 0.87 RAB9A (0.54) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL4905135 0.86 RAB9A (0.53) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL9287533 0.86 CCR1 (0.54) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL16159692 0.86 RAB9A (0.53) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL16159738 0.86 RAB9A (0.53) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL9282401 0.86 RAB9A (0.49) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL16159715 0.86 RAB9A (0.53) RAB9AHSP90AA1PDPK1SYKSRC
SCHEMBL17704348 0.84 RAB9A (0.51) RAB9AHSP90AA1PDPK1SYKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706938-B2 Photoelectric conversion element and photoelectric conversion module RICOH COMPANY, LTD. (JP) 2023-07-18 US disclosed
US-11706938-B2 Photoelectric conversion element and photoelectric conversion module RICOH COMPANY, LTD. (JP) 2023-07-18 US disclosed
US-20230171975-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, ELECTRONIC DEVICE, AND PARTITION RICOH COMPANY, LTD., (JP) 2023-06-01 US disclosed
US-20230171975-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, ELECTRONIC DEVICE, AND PARTITION RICOH COMPANY, LTD., (JP) 2023-06-01 US disclosed
US-20230142134-A1 PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT MODULE RICOH COMPANY, LTD. (JP) 2023-05-11 US disclosed
US-20230142134-A1 PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT MODULE RICOH COMPANY, LTD. (JP) 2023-05-11 US disclosed
US-20230134849-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, AND ELECTRONIC DEVICE RICOH COMPANY, LTD. (JP) 2023-05-04 US disclosed
US-20230134849-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, AND ELECTRONIC DEVICE RICOH COMPANY, LTD. (JP) 2023-05-04 US disclosed
EP-4174888-A1 PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT MODULE Ricoh Company, Ltd. (JP) 2023-05-03 EP disclosed
US-20220392714-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, ELECTRONIC DEVICE, AND POWER SUPPLY MODULE RICOH COMPANY, LTD. (JP) 2022-12-08 US disclosed
US-10693092-B2 Photoelectric conversion element and solar cell RICOH COMPANY, LTD. (JP) 2020-06-23 US disclosed
US-20190305168-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION ELEMENT MODULE, ELECTRONIC DEVICE, AND POWER SUPPLY MODULE RICOH COMPANY, LTD. (JP) 2019-10-03 US disclosed
CN-109651358-A 4-aminopyridine derivative, its pharmaceutical composition, preparation method and application 上海迪诺医药科技有限公司 2019-04-19 CN disclosed
US-20180198083-A1 PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL RICOH COMPANY, LTD. (JP) 2018-07-12 US disclosed
US-20180198083-A1 PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL RICOH COMPANY, LTD. (JP) 2018-07-12 US disclosed
US-20160276609-A1 DYE-SENSITIZED SOLAR CELL RICOH COMPANY, LTD. (JP) 2016-09-22 US disclosed
US-20160276609-A1 DYE-SENSITIZED SOLAR CELL RICOH COMPANY, LTD. (JP) 2016-09-22 US disclosed
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 RAB9A 3132/4885HSP90AA1 3995/4885PDPK1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.